RxDoctor Payments Data

Jennifer Smith

Nurse Practitioner · Brookhaven, MSNPI 1063180420

Payments from drug & device makers

$230in general payments, 2019–2025

Across 15 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$64
  • AbbVie$53
  • Novo Nordisk$25
  • AstraZeneca$25
  • Astellas Pharma US Inc$21
  • Axonics, Inc.$17
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$230100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$230 in reported general payments places this provider in the 50th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$35,040
Medicare patients
146
Services billed
979

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin67$77,113
OzempicSemaglutide62$59,252
FarxigaDapagliflozin Propanediol63$48,912
EliquisApixaban37$40,386
LinzessLinaclotide37$27,178
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$10,162
Tresiba Flextouch U-200Insulin Degludec11$7,142
SymbicortBudesonide/Formoterol Fumarate18$4,118
Novolog FlexpenInsulin Aspart14$2,208
Albuterol Sulfate HfaAlbuterol Sulfate70$1,612
Rosuvastatin Calcium172$1,372
Gabapentin131$1,216
Amlodipine Besylate244$1,020
Carbamazepine12$1,008
Atorvastatin Calcium165$988

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$64$77,11367 claims
Novo NordiskOzempic, Novolog Mix 70-30$25$60,00373 claims
AstraZenecaFarxiga, Symbicort$25$53,03081 claims
AbbVieLinzess$53$27,17837 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Brookhaven

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →